Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morag Park

Showing results (21-30 of 195) with videos related to

Pageof 20
Sort By:
The Journal of Biological Chemistry|July 26, 2002
Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic programLouie Lamorte, Sonia Rodrigues, Monica Naujokas, et al.
Molecular Biology of the Cell|April 11, 2003
Membrane targeting of Grb2-associated binder-1 (Gab1) scaffolding protein through Src myristoylation sequence substitutes for Gab1 pleckstrin homology domain and switches an epidermal growth factor response to an invasive morphogenic programChristiane R Maroun, Monica A Naujokas, Morag Park
The Journal of Biological Chemistry|December 12, 2002
Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1Helena L Palka, Morag Park, Nicholas K Tonks
Molecular Biology of the Cell|May 15, 2002
Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctionsLouie Lamorte, Isabelle Royal, Monica Naujokas, et al.
Journal of Cellular Physiology|September 27, 2007
Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptorMelanie M Frigault, Monica A Naujokas, Morag Park
Medecine Sciences : M/S|June 2, 2009
[The tumor microenvironment: a new tool to predict breast cancer outcome]Greg Finak, Julie Laferrière, Michael Hallett, et al.
The Journal of Cell Biology|October 9, 2019
Arf6 regulates RhoB subcellular localization to control cancer cell invasionKossay Zaoui, Charles V Rajadurai, Stéphanie Duhamel, et al.
Cancers|June 2, 2021
Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα PathwayFaegheh Ghanbari, Anne-Marie Fortier, Morag Park, et al.
Traffic (Copenhagen, Denmark)|December 12, 2018
CLIP-170 spatially modulates receptor tyrosine kinase recycling to coordinate cell migrationKossay Zaoui, Stephanie Duhamel, Christine A Parachoniak, et al.
Future Drug Discovery|May 23, 2022
The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?Gabrielle Brewer, Anne-Marie Fortier, Morag Park, et al.
Pageof 20

Showing results (21-30 of 195) with videos related to

Sort By:
Pageof 20
The Journal of Biological Chemistry|July 26, 2002
Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic programLouie Lamorte, Sonia Rodrigues, Monica Naujokas, et al.
Molecular Biology of the Cell|April 11, 2003
Membrane targeting of Grb2-associated binder-1 (Gab1) scaffolding protein through Src myristoylation sequence substitutes for Gab1 pleckstrin homology domain and switches an epidermal growth factor response to an invasive morphogenic programChristiane R Maroun, Monica A Naujokas, Morag Park
The Journal of Biological Chemistry|December 12, 2002
Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1Helena L Palka, Morag Park, Nicholas K Tonks
Molecular Biology of the Cell|May 15, 2002
Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctionsLouie Lamorte, Isabelle Royal, Monica Naujokas, et al.
Journal of Cellular Physiology|September 27, 2007
Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptorMelanie M Frigault, Monica A Naujokas, Morag Park
Medecine Sciences : M/S|June 2, 2009
[The tumor microenvironment: a new tool to predict breast cancer outcome]Greg Finak, Julie Laferrière, Michael Hallett, et al.
The Journal of Cell Biology|October 9, 2019
Arf6 regulates RhoB subcellular localization to control cancer cell invasionKossay Zaoui, Charles V Rajadurai, Stéphanie Duhamel, et al.
Cancers|June 2, 2021
Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα PathwayFaegheh Ghanbari, Anne-Marie Fortier, Morag Park, et al.
Traffic (Copenhagen, Denmark)|December 12, 2018
CLIP-170 spatially modulates receptor tyrosine kinase recycling to coordinate cell migrationKossay Zaoui, Stephanie Duhamel, Christine A Parachoniak, et al.
Future Drug Discovery|May 23, 2022
The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?Gabrielle Brewer, Anne-Marie Fortier, Morag Park, et al.
Pageof 20